Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

Two new studies will investigate whether SGLT-2 inhibitor Jardiance impacts heart failure in people with and without diabetes. Jardiance is already approved to lower A1C...
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective; it is recruiting 1,800 participants with type 2...
A new trial will test if the once-weekly injectable, Bydureon, is also safe and effective in adolescents.
Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic...
Phase 3 clinical trial currently recruiting 400 adults with type 2 diabetes
The S-ICD is an FDA-approved device that can prevent sudden cardiac arrest; this trial is testing it in people with diabetes who’ve had prior heart attacks with...
Contribute data to a new study on how overnight blood sugars affect sleep, activity, and mental state; four-week “virtual” trial recruiting people with type 1 on Dexcom...
A new study will investigate whether SGLT-2 inhibitor Farxiga can delay the progression of heart failure in people with and without type 2 diabetes
A study is enrolling over 100 people with type 2 between the ages of 10 and 18 years, examining Jardiance and Tradjenta
A trial is enrolling over 2,000 people in any Anthem health plan with type 2 diabetes
The SWITCH PRO trial will examine whether Tresiba improves blood sugar management more than Lantus, as measured by FreeStyle Libre Pro; now recruiting at 67 locations...
The study aims to enroll about 1,800 adults with type 2 diabetes at increased risk of heart disease
DIY Loop virtual study requires no in-person visits and seeks 300-1,000 Loop users, especially those new to Looping. Data will support eventual FDA submission of...
A study recruiting 10,000 people will look at whether Zynquista (sotagliflozin) has effects beyond glucose-lowering and weight loss
The first trial, now recruiting 50 people, is an observational study of insulin requirements and glucose levels using the Dexcom G6 CGM in type 1 pregnancy.
A trial in Boston is enrolling 168 individuals ages 65 years and older with type 1 diabetes to investigate the combination of CGM and education to reduce hypoglycemia
A currently-recruiting trial is comparing how two types of basal insulin – Toujeo and Tresiba – impact blood sugar levels in adults, using continuous glucose monitoring
This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years)
This currently recruiting study will support FDA submission of Tandem’s Control-IQ hybrid closed loop for children six years of age or older
A trial is enrolling over 3,000 individuals living with type 2 diabetes and chronic kidney disease

Pages